Cover Image

Pimobendan Inhibits HBV Transcription and Replication by Suppressing HBV Promoters Activity

Current anti-HBV therapeutic strategy relies on interferon and nucleos(t)ide-type drugs with the limitation of functional cure, inducing hepatitis B surface antigen (HBsAg) loss in very few patients. Notably, the level of HBsAg has been established as an accurate indicator to evaluate the drug effic...

Full description

Saved in:

Bibliographic Details
Main Authors:	Si-Yu Yuan (Author), Hai-Bo Yu (Author), Zhen Yang (Author), Yi-Ping Qin (Author), Ji-Hua Ren (Author), Sheng-Tao Cheng (Author), Fang Ren (Author), Betty Yuen Kwan Law (Author), Vincent Kam Wai Wong (Author), Jerome P. L. Ng (Author), Yu-Jiao Zhou (Author), Xin He (Author), Ming Tan (Author), Zhen-Zhen Zhang (Author), Juan Chen (Author)
Format:	Book
Published:	Frontiers Media S.A., 2022-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The unique antibody suppresses HBV viremia and reduces hepatocarcinogenesis in HBV-transgenic mice
by: Xiao-Zhen Kang, et al.
Published: (2018)

A glycoengineered therapeutic anti-HBV antibody that allows increased HBsAg immunoclearance improves HBV suppression in vivo
by: Min You, et al.
Published: (2023)

Chinese Patent Medicine Liuweiwuling Tablet had Potent Inhibitory Effects on Both Wild-Type and Entecavir-Resistant Hepatitis B Virus (HBV) in vitro and Effectively Suppressed HBV Replication in Mouse Model
by: Fei-lin Ge, et al.
Published: (2021)

Sustained Inhibition of HBV Replication In Vivo after Systemic Injection of AAVs Encoding Artificial Antiviral Primary MicroRNAs
by: Mohube Betty Maepa, et al.
Published: (2017)

HBV and HIV/HBV Infected Patients Have Distinct Immune Exhaustion and Apoptotic Serum Biomarker Profiles
by: Mohamed Tarek M. Shata, et al.
Published: (2019)

Comprehensive investigation of HBV-related hepatocellular carcinoma and choice of anti-HBV therapy
by: Huihui Lu, et al.
Published: (2021)

The role of Traditional Chinese medicine in anti-HBV: background, progress, and challenges
by: Feilin Ge, et al.
Published: (2023)

The Culprit Behind HBV-Infected Hepatocytes: NTCP
by: Li S, et al.
Published: (2024)

The Role Placental TLR-7 Expression with Cord Blood HBV DNA and Placental HBV DNA
by: Naeny Fajriah, et al.
Published: (2022)

The epidemiological changes of HCV and HBV infections in the era of new antiviral therapies and the anti-HBV vaccine
by: Cristina Stasi, et al.
Published: (2016)

In situ analysis of hepatitis B virus (HBV) antigen and DNA in HBV-induced hepatocellular carcinoma
by: Ye Zheng, et al.
Published: (2022)

The Sterile Inflammation in the Exacerbation of HBV-Associated Liver Injury
by: Qiao Yang, et al.
Published: (2015)

Improved pharmacokinetics of tenofovir ester prodrugs strengthened the inhibition of HBV replication and the rebalance of hepatocellular metabolism in preclinical models
by: Xiaodan Hong, et al.
Published: (2022)

Enrichment of Ly6Chi monocytes by multiple GM-CSF injections with HBV vaccine contributes to viral clearance in a HBV mouse model
by: Weidong Zhao, et al.
Published: (2017)

Immunological response of Hepatitis B Virus Surface Antigen in HBV Mono and HBV/HDV Co-infection
by: Mehwish Sajjad, et al.
Published: (2024)

HBV genome-enriched single cell sequencing revealed heterogeneity in HBV-driven hepatocellular carcinoma (HCC)
by: Wenhui Wang, et al.
Published: (2022)

Seroprevalence of HIV-HBV Co-Infection
by: Suresh B. Sonth, et al.
Published: (2012)

Prevention strategies of mother‐to‐child transmission of hepatitis B virus (HBV) infection
by: Yao Hu, et al.
Published: (2020)

New progress in HBV control and the cascade of health care for people living with HBV in China: evidence from the fourth national serological survey, 2020Research in context
by: Zheng Hui, et al.
Published: (2024)

HIV Therapy without HBV Co-management in Ethiopia Fosters Emergence of Unintended HBV Drug Resistance and Vaccine Evasive Variants
by: Y.B. Akal, et al.
Published: (2017)

Liver-Targeted Anti-HBV Single-Stranded Oligonucleotides with Locked Nucleic Acid Potently Reduce HBV Gene Expression In Vivo
by: Hassan Javanbakht, et al.
Published: (2018)

Search for chronic HBV infection curative therapies
by: Markus Cornberg
Published: (2016)

Fance deficiency inhibits primordial germ cell proliferation associated with transcription-replication conflicts accumulate and DNA repair defects
by: Zhixian Zhou, et al.
Published: (2023)

SIRT6 Inhibitor, OSS_128167 Restricts Hepatitis B Virus Transcription and Replication Through Targeting Transcription Factor Peroxisome Proliferator-Activated Receptors α
by: Hui Jiang, et al.
Published: (2019)

Seroprevalence of anti-HBc, risk factors of occupationally acquired HBV infection and HBV vaccination among hospital staff in Poland: a multicenter study
by: Maria Ganczak, et al.
Published: (2019)

Evaluation of the effect of three disinfectants on removing HBV contamination
by: Arami S, et al.
Published: (2006)

THE CYTOKINE IP-10 IN CHRONIC HBV AND HCV INFECTION
by: Nina S. Nikolova, et al.
Published: (2013)

Epidemiology of HBV in Pregnant Women, South West Nigeria
by: Glory Atilola, et al.
Published: (2018)

Justification for screening programs for early detection of HBV infections
by: Małgorzata Leźnicka, et al.
Published: (2014)

A review on the epidemiology of HBV and HIV co-infection
by: Asaad Mohd, et al.
Published: (2023)

Heme and HO-1 inhibition of HCV, HBV, and HIV
by: Warren N Schmidt, et al.
Published: (2012)

Inactivated COVID-19 vaccines, HBV and HIV: Correspondence
by: Pathum Sookaromdee, et al.
Published: (2022)

EPIDEMIOLOGICAL PATTERNS OF CHRONIC HBV-INFECTION IN FAMILY CASES
by: F. I. Inoyatova, et al.
Published: (2016)

Hurdles to the Development of Effective HBV Immunotherapies and HCV Vaccines
by: Almudena Torres-Cornejo, et al.
Published: (2017)

ROS/NF-κB Signaling Pathway-Mediated Transcriptional Activation of TRIM37 Promotes HBV-Associated Hepatic Fibrosis
by: Haina Xie, et al.
Published: (2020)

Relative indoleamine 2,3-dioxygenase transcript level concerning anti-HBs titers in response to HBV vaccination in hemodialysis patients
by: Alicja E. Grzegorzewska, et al.
Published: (2018)

The CRISPR/Cas9 System Facilitates Clearance of the Intrahepatic HBV Templates In Vivo
by: Su-Ru Lin, et al.
Published: (2014)

Risk of HBV infection among male and female first-time blood donors born before and after the July 1986 HBV vaccination program in Taiwan
by: Hsuan-Hui Wang, et al.
Published: (2021)

Closing the gap to achieve HBV elimination by 2030: A global pursuit fueled by regional successes
by: Robert J. Wong
Published: (2021)

Design and analysis considerations for early phase clinical trials in hepatitis B (HBV) cure research: the ACTG A5394 study in persons with both HIV and HBV
by: Minhee Kang, et al.
Published: (2023)